By Product
Currency:CNY
2025/H1
Stock NameRevenueRatio
Cardio-cerebrovascular class268.84M87.12%
Antibiotics17.56M5.69%
APIs and intermediates5.2M1.68%
Digestive class4.63M1.50%
Antiviral class4.52M1.47%
Other business2.56M0.83%
Immune regulatory class2.48M0.80%
Other classes1.75M0.57%
Diuretics1.04M0.34%
View all
By Industry
Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry504.36M100.00%
By Country/Region
Currency:CNY
2025/H1
Stock NameRevenueRatio
East China region122.06M39.55%
North China81.18M26.31%
South China32.93M10.67%
Central China28.87M9.36%
Northwest region16.19M5.25%
Southwest area14.61M4.74%
Northeast area10.17M3.30%
Other business2.56M0.83%
View all
